Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

Paper Chase #5 | Concerning a Cholesterol Drug We’ve Never Heard Of: Anacetrapib

Andrew Buelt, DO and Joe Weatherly, DO
00:00
05:08
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Dollars to donuts, the CETP inhibitors like anacetrapib are not part of your primary care pharmacologic arsenal. And this study shows why they never will be.

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
A Feverish Frenzy! Full episode audio for MD edition 203:03 min - 95 MB - M4AHippo Primary Care RAP - January 2018 Summary 386 KB - PDF